4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy

Ulrike B S Hedrich, Stephan Lauxmann, Markus Wolff, Matthis Synofzik, Thomas Bast, Adrian Binelli, José M Serratosa, Pedro Martínez-Ulloa, Nicholas M Allen, Mary D King, Kathleen M Gorman, Bruria Ben Zeev, Michal Tzadok, Lily Wong-Kisiel, Dragan Marjanovic, Guido Rubboli, Sanjay M Sisodiya, Florian Lutz, Harshad Pannikkaveettil Ashraf, Kirsten TorgePu Yan, Christian Bosselmann, Niklas Schwarz, Monika Fudali, Holger Lerche

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstrakt

[Figure: see text].

OriginalsprogEngelsk
Sider (fra-til)eaaz4957
TidsskriftScience Translational Medicine
Vol/bind13
Udgave nummer609
DOI
StatusUdgivet - sep. 2021

Fingeraftryk

Udforsk hvilke forskningsemner '4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy' indeholder.

Citationsformater